February 15-17, 2024  •  Hilton Midtown  •  New York, NY

Session Details

The Latest in Longevity Medicine: Predictive Genomics

Feb 17 2024

12:30 PM - 1:30 PM EDT

Today’s healthcare approaches are embracing precision medicine, or as the FDA defines it, “tailoring disease prevention and treatment that takes into account differences in people’s genes, environments, and lifestyles.” Predictive genomics is one of many pieces of precision medicine landscape. While traditionally we are used to predictive genomics related to oncology treatment or high-penetrant germline variant identification, there are more technologies available to clinicians that enable the integration of predictive genomics into the clinical care continuum. Focusing on the prevention and risk-reduction side of predictive genomics, this session will cover the expansion beyond high-penetrant disease susceptibility screening to include the state of population-level predictive genomics, or “polygenic risk.” We will also discuss the value of integrating predictive genomics with traditional clinical care to achieve personalized or precision medicine approach to wellness allowing for more informed decision-making discussions between healthcare providers and patients when considering disease screening and risk-reducing options.

Learning Objectives:

  1. Explain the basics of predictive genomics.
  2. Explain how predictive genomics impacts longevity medicine.
  3. Explain the actionable interventions to alter predictive genomics outcomes.


The Institute for Functional Medicine

- Chief of Medical Affairs

© Diversified Communications. All rights reserved.